Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 3701 - 3800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3701 | 25072524 |
US |
5 | 1 |
Overdose, Erythema, Skin haemorrhage, Product storage error, Injection site pain, Rash, Intentional product misuse, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, CRISABOROLE, |
||||
| 3702 | 25072662 |
CL |
47 | 2 |
Pancreatitis, Overdose, Device malfunction, Device delivery system issue, Panic attack, Malaise, Dehydration, Insomnia, Anxiety, Crying, Thirst, Anuria, Disturbance in attention, Asthenia, Diarrhoea, Dizziness, Gastrooesophageal reflux disease, Vomiting, Nausea, Abdominal pain upper, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 3703 | 25073175 |
US |
42 | 1 |
Hospitalisation, Generalised tonic-clonic seizure, Postictal state, Therapy interrupted, Overdose, |
||||
BRIVARACETAM, |
||||
| 3704 | 25073190 |
BE |
13 | 2 |
Vomiting, Overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3705 | 25073197 |
BE |
1 | |
Abdominal pain, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3706 | 25073253 |
US |
46 | 1 |
Alopecia, Erythema, Inappropriate schedule of product administration, Overdose, Suspected counterfeit product, |
||||
| 3707 | 25073482 |
US |
||
Suicide attempt, Respiratory failure, Metabolic acidosis, Hypercapnia, Mental status changes, Hypoxia, Lethargy, Vasoplegia syndrome, Blood creatinine increased, Intentional overdose, Overdose, Hypotension, |
||||
LEVOTHYROXINE, PANTOPRAZOLE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, METOPROLOL TARTRATE, METOPROLOL, AMLODIPINE, MIRTAZAPINE, MELATONIN, |
||||
| 3708 | 25073514 |
US |
32 | 2 |
Hypoglycaemia, Hypothermia, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 3709 | 25073665 |
US |
||
Overdose, No adverse event, |
||||
RISDIPLAM, |
||||
| 3710 | 25073676 |
US |
52 | |
Injection site pain, Injection site haemorrhage, Injection site urticaria, Overdose, |
||||
DULAGLUTIDE, |
||||
| 3711 | 25074315 |
FR |
2 | 2 |
Diarrhoea, Anaemia, Incorrect dose administered, Overdose, |
||||
AZITHROMYCIN DIHYDRATE, |
||||
| 3712 | 25074398 |
AU |
35 | |
Overdose, Cardiac arrest, Hypoxia, Multiple organ dysfunction syndrome, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BACLOFEN, PROPRANOLOL HYDROCHLORIDE, |
||||
| 3713 | 25074588 |
US |
21 | 2 |
Cardiac arrest, Pulseless electrical activity, Shock, Lactic acidosis, Procedural complication, Hypothermia, Hypoglycaemia, Abdominal pain, Agitation, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 3714 | 25074722 |
US |
24 | 2 |
Hypothermia, Hypoglycaemia, Overdose, Product use in unapproved indication, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 3715 | 25075192 |
AU |
||
Delirium, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 3716 | 25075494 |
US |
||
Overdose, Drug dependence, Impaired quality of life, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 3717 | 25075500 |
US |
1 | |
Overdose, Drug dependence, Impaired quality of life, Mental disorder, Post-traumatic stress disorder, Social anxiety disorder, Depression, Social problem, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 3718 | 25076034 |
US |
77 | 2 |
Application site pruritus, Application site acne, Application site rash, Overdose, |
||||
MINOXIDIL, |
||||
| 3719 | 25076166 |
US |
24 | 2 |
General anaesthesia, Implant site scar, Device issue, Device issue, Device deployment issue, Complication associated with device, Complication of device removal, Product quality issue, Overdose, |
||||
ETONOGESTREL, ETONOGESTREL, ETONOGESTREL, |
||||
| 3720 | 25076209 |
US |
2 | |
Product use in unapproved indication, Therapeutic response unexpected, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, DAPAGLIFLOZIN, LORATADINE, LORATADINE ORAL, |
||||
| 3721 | 25076318 |
US |
||
Overdose, Seizure, Agitation, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, FLUMAZENIL, |
||||
| 3722 | 25076443 |
PL |
14 | 2 |
International normalised ratio increased, Electrolyte imbalance, Vomiting, Dizziness, Toxicity to various agents, Overdose, Drug abuse, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3723 | 25076455 |
US |
49 | 1 |
Arthralgia, Mobility decreased, Pain, Pruritus, Rash, Overdose, Injection site reaction, |
||||
IXEKIZUMAB, |
||||
| 3724 | 25076746 |
US |
18 | 1 |
Arrhythmic storm, Cardiac arrest, Overdose, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 3725 | 25066079 |
IT |
16 | 2 |
Heart rate increased, Loss of consciousness, Overdose, |
||||
ASENAPINE MALEATE, TRIAZOLAM, BUPROPION HYDROCHLORIDE, MIRTAZAPINE, |
||||
| 3726 | 25066131 |
US |
||
Drug ineffective, Overdose, |
||||
| 3727 | 25066948 |
IT |
47 | 2 |
Drug abuse, Intentional self-injury, Bradyphrenia, Sopor, Intentional product misuse, Overdose, |
||||
ALPRAZOLAM, |
||||
| 3728 | 25067171 |
US |
65 | 2 |
Overdose, |
||||
IXEKIZUMAB, |
||||
| 3729 | 25067234 |
CO |
||
Gastrointestinal disorder, Iron deficiency anaemia, Eczema, Gastrointestinal haemorrhage, Eczema, Spinal pain, Pelvic pain, Ill-defined disorder, Dry skin, Fatigue, Arthralgia, Arthralgia, Gastroenteritis, Therapeutic response shortened, Intentional dose omission, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 3730 | 25067238 |
FR |
12 | 1 |
Dysstasia, Overdose, Off label use, |
||||
RISPERIDONE, RISPERIDONE, |
||||
| 3731 | 25067460 |
PL |
||
Iridocyclitis, Overdose, |
||||
MELPHALAN HYDROCHLORIDE, MELPHALAN, MELPHALAN HYDROCHLORIDE, MELPHALAN, |
||||
| 3732 | 25067562 |
NL |
||
Post-injection delirium sedation syndrome, Sinus tachycardia, Electrocardiogram QT prolonged, Antipsychotic drug level increased, Hypertension, Overdose, |
||||
OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, |
||||
| 3733 | 25068034 |
IT |
81 | 1 |
Cerebral haematoma, Cerebral haemorrhage, Overdose, Medication error, |
||||
FONDAPARINUX SODIUM, FUROSEMIDE, FUROSEMIDE, PANTOPRAZOLE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 3734 | 25068252 |
US |
56 | 2 |
Overdose, Blood pressure increased, Burning sensation, Ocular hyperaemia, Fatigue, Drug ineffective, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3735 | 25068536 |
US |
16 | 1 |
Bradycardia, Mental status changes, Overdose, Self-medication, Intentional product misuse, |
||||
ALPRAZOLAM, ALPRAZOLAM, LORAZEPAM, LORAZEPAM, |
||||
| 3736 | 25068795 |
CA |
44 | 2 |
Systemic lupus erythematosus, Overdose, Off label use, |
||||
SARILUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERYTHROMYCIN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, |
||||
| 3737 | 25069271 |
GB |
62 | 1 |
Staphylococcal infection, Incontinence, Confusional state, Overdose, White blood cell count decreased, Neutrophil count decreased, Neutrophil count increased, Platelet count decreased, |
||||
CLOZAPINE, |
||||
| 3738 | 25069343 |
US |
||
Generalised tonic-clonic seizure, Viral infection, Sepsis, Urinary tract infection, Overdose, |
||||
TROFINETIDE, |
||||
| 3739 | 25069408 |
US |
15 | 2 |
Somnolence, Overdose, Hypotension, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TRANEXAMIC ACID, ZOLPIDEM TARTRATE, CLONAZEPAM, AMLODIPINE, |
||||
| 3740 | 25069411 |
US |
45 | 2 |
Suspected suicide attempt, Depressed level of consciousness, Agitation, Bradycardia, Hyperthermia, Hypertension, Nervous system disorder, Overdose, Mutism, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, BISOPROLOL FUMARATE, |
||||
| 3741 | 25069621 |
US |
19 | 1 |
Counterfeit product administered, Overdose, Drug abuse, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 3742 | 25069627 |
US |
46 | 1 |
Counterfeit product administered, Overdose, Drug abuse, Drug screen positive, |
||||
BUPRENORPHINE, DRONABINOL, FENTANYL, |
||||
| 3743 | 25069631 |
US |
58 | 1 |
Overdose, Drug abuse, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL, |
||||
| 3744 | 25069672 |
FR |
16 | 2 |
Cognitive disorder, Disorientation, Headache, Hallucinations, mixed, Sinus tachycardia, Drug abuse, Overdose, Drug diversion, Toxicity to various agents, Confusional state, Disorganised speech, Mydriasis, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, SERTRALINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, HYDROXYZINE, HYDROXYZINE, |
||||
| 3745 | 25070319 |
PL |
||
Vomiting, Dizziness, Electrolyte imbalance, International normalised ratio increased, Overdose, Toxicity to various agents, Toxicity to various agents, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SERTRALINE, |
||||
| 3746 | 25070876 |
US |
40 | 1 |
Cardiac failure, Suicide attempt, Renal disorder, Cardiac failure congestive, Mental disorder, Hyperlipidaemia, Left ventricular enlargement, Left ventricular hypertrophy, Left ventricular dysfunction, Myocardial infarction, Drug abuse, Hypertension, Pulmonary oedema, Vision blurred, Dyspnoea exertional, Chest discomfort, Dizziness, Chest pain, Fatigue, Oedema peripheral, Palpitations, Dyspnoea, Overdose, Product dose omission issue, Chronic kidney disease, Essential hypertension, |
||||
DAPAGLIFLOZIN, HYDRALAZINE HYDROCHLORIDE, CLONIDINE, |
||||
| 3747 | 25061618 |
SE |
16 | 2 |
Intentional self-injury, Intentional overdose, Poisoning deliberate, Overdose, |
||||
SERTRALINE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 3748 | 25062094 |
US |
21 | 1 |
Cardiotoxicity, Unresponsive to stimuli, Seizure, Arrhythmia, Cardiogenic shock, Bundle branch block left, Hypokinesia, Ejection fraction decreased, Overdose, |
||||
BUPROPION, |
||||
| 3749 | 25062365 |
US |
65 | 2 |
Wrong technique in product usage process, Overdose, |
||||
ALBUTEROL SULFATE, |
||||
| 3750 | 25062885 |
CN |
||
Asthma, Wrong technique in device usage process, Inappropriate schedule of product administration, Overdose, Product prescribing error, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 3751 | 25063339 |
US |
2 | |
Encephalopathy, Seizure, Cardiac arrest, Circulatory collapse, Shock, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 3752 | 25064685 |
US |
2 | |
Somnolence, Product use in unapproved indication, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, SIMVASTATIN, MELOXICAM, GABAPENTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OMALIZUMAB, |
||||
| 3753 | 25065293 |
US |
2 | 1 |
Overdose, Off label use, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 3754 | 25065690 |
AU |
81 | 1 |
Product adhesion issue, Overdose, Product dose omission issue, |
||||
ROTIGOTINE, ROTIGOTINE, |
||||
| 3755 | 25056960 |
US |
||
Encephalopathy, Shock, Cardiac arrest, Seizure, Overdose, |
||||
BUPROPION, |
||||
| 3756 | 25057930 |
ZA |
46 | 2 |
Heart rate increased, Drug ineffective, Overdose, Feeling abnormal, |
||||
| 3757 | 25058733 |
US |
17 | 2 |
Nausea, Vomiting, Overdose, Intentional overdose, |
||||
TRANEXAMIC ACID, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CAFFEINE, |
||||
| 3758 | 25059030 |
NL |
64 | 1 |
Toxicity to various agents, Post-injection delirium sedation syndrome, Electrocardiogram QT prolonged, Hypertension, Muscle rigidity, Overdose, Off label use, Off label use, |
||||
OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 3759 | 25059100 |
US |
37 | 1 |
Overdose, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 3760 | 25059597 |
GB |
1 | |
Blood creatine phosphokinase increased, Overdose, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, LITHIUM, LITHIUM BROMATUM, RIVAROXABAN, |
||||
| 3761 | 25060807 |
BE |
1 | |
General symptom, Abdominal pain, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3762 | 25054837 |
US |
58 | 2 |
Acute myocardial infarction, Acute respiratory failure, Autoimmune hepatitis, Chronic hepatic failure, Transaminases increased, Anaemia, Abdominal pain, Asthenia, Jaundice, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3763 | 25055241 |
EU |
1 | |
Drug abuse, Accidental death, Overdose, Non-cardiogenic pulmonary oedema, Acute pulmonary oedema, Drug dependence, Intentional product misuse, Toxicity to various agents, Drug interaction, Suicide attempt, |
||||
FENTANYL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ALPRAZOLAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ZOLPIDEM TARTRATE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PROPOFOL, CLONAZEPAM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 3764 | 25048409 |
US |
2 | |
Renal impairment, Headache, Fatigue, Underdose, Product dose omission issue, Overdose, |
||||
OLAPARIB, |
||||
| 3765 | 25048489 |
US |
29 | 2 |
Overdose, Product complaint, |
||||
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 3766 | 25049138 |
US |
2 | |
Brain death, Shock, Overdose, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 3767 | 25049211 |
US |
1 | |
Incorrect dose administered, Product dose omission issue, Overdose, Seasonal allergy, Device malfunction, Device delivery system issue, Allergy to animal, Drug delivery system malfunction, Wheezing, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 3768 | 25049352 |
US |
2 | |
Circulatory collapse, Shock, Encephalopathy, Overdose, Seizure, Cardiac arrest, |
||||
BUPROPION, |
||||
| 3769 | 25049600 |
US |
1 | 2 |
Respiratory syncytial virus infection, Nasopharyngitis, Cough, Overdose, Product prescribing error, Product dose omission issue, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, MELATONIN, |
||||
| 3770 | 25049759 |
US |
2 | |
Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 3771 | 25050198 |
BR |
21 | 2 |
Overdose, Headache, |
||||
NUSINERSEN, NUSINERSEN, |
||||
| 3772 | 25050266 |
EU |
70 | 1 |
Gastrointestinal anastomotic leak, Diarrhoea, Hypotension, Pancytopenia, Off label use, Overdose, Underdose, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, OXALIPLATIN, OXALIPLATIN, TRASTUZUMAB, TRASTUZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 3773 | 25050298 |
CA |
58 | 2 |
Bursitis, Asthma, Psoriasis, Food allergy, Retching, Fluid retention, Hepatic enzyme increased, Exposure during pregnancy, Pyrexia, Headache, Foetal death, Overdose, Cardiac failure, Infection, Temperature regulation disorder, Constipation, Drug ineffective, Joint swelling, Back pain, Prescribed overdose, Upper respiratory tract infection, Erythema, Hyponatraemia, Drug intolerance, Rash, Immunodeficiency, Hypertension, Pain, Decreased immune responsiveness, Drug hypersensitivity, Off label use, Product use issue, Hyperhidrosis, Infusion related reaction, Coeliac disease, Fatigue, Thrombocytopenia, Rheumatoid arthritis, Rash erythematous, Nausea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALBUTEROL SULFATE, ALBUTEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TOCILIZUMAB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, PROGESTERONE, BUPROPION HYDROCHLORIDE, CLONIDINE, |
||||
| 3774 | 25051418 |
AU |
||
Acute hepatic failure, Overdose, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3775 | 25051419 |
AU |
||
Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3776 | 25051422 |
AU |
||
Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3777 | 25051458 |
US |
||
Brain neoplasm, Seizure, Loss of consciousness, Overdose, Loss of employment, |
||||
BRIVARACETAM, ZOLPIDEM TARTRATE, LORAZEPAM, |
||||
| 3778 | 25051737 |
AU |
||
Hepatotoxicity, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 3779 | 25051921 |
US |
1 | |
Overdose, Drug dependence, Drug abuse, Impaired quality of life, Emotional distress, Pain, Drug withdrawal syndrome, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 3780 | 25052127 |
JP |
2 | |
Death, Overdose, |
||||
IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, |
||||
| 3781 | 25052486 |
US |
||
Skin irritation, Acne, Condition aggravated, Drug ineffective, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, |
||||
| 3782 | 25052487 |
US |
||
Drug ineffective, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, |
||||
| 3783 | 25052503 |
US |
||
Dry skin, Drug ineffective, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, |
||||
| 3784 | 25054500 |
CH |
86 | 1 |
Aortic aneurysm, Food refusal, Hallucination, Intentional medical device removal by patient, Refusal of treatment by patient, Agitation, Akinesia, Overdose, Clostridial infection, Confusional state, |
||||
| 3785 | 25043598 |
FR |
81 | 2 |
Gastrointestinal haemorrhage, Vomiting, Gastrooesophageal reflux disease, Diarrhoea, Overdose, |
||||
OSIMERTINIB, OSIMERTINIB, IRBESARTAN, PROPYLTHIOURACIL, LEUCOVORIN CALCIUM, BISOPROLOL FUMARATE, |
||||
| 3786 | 25043949 |
FR |
48 | 1 |
Hepatitis toxic, Renal failure, Overdose, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OBINUTUZUMAB, ISONIAZID, METHYLPREDNISOLONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, COLCHICINE, IVERMECTIN, LEVOTHYROXINE, ENTECAVIR, ENTECAVIR ANHYDROUS, RAMIPRIL, LANSOPRAZOLE, TRAMADOL HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MORPHINE, MORPHINE, HYDROXYZINE, HYDROXYZINE, PREDNISONE, LEVOTHYROXINE, |
||||
| 3787 | 25044049 |
FR |
71 | 2 |
Drug use disorder, Confusional state, Overdose, |
||||
OXYCODONE, |
||||
| 3788 | 25044055 |
TR |
14 | 2 |
Anuria, Hypotension, Suicide attempt, Toxicity to various agents, Somnolence, Overdose, |
||||
AMLODIPINE, |
||||
| 3789 | 25044521 |
DE |
43 | 2 |
Overdose, Circadian rhythm sleep disorder, Altered state of consciousness, Abnormal behaviour, Aggression, Irritability, Anxiety, |
||||
PROPOFOL, |
||||
| 3790 | 25044944 |
US |
15 | 2 |
Somnolence, Intentional overdose, Overdose, Hypotension, |
||||
AMLODIPINE, TRANEXAMIC ACID, CLONAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ZOLPIDEM TARTRATE, |
||||
| 3791 | 25045267 |
EU |
66 | 1 |
Overdose, Coma, |
||||
MORPHINE, |
||||
| 3792 | 25045292 |
CA |
40 | 2 |
Bursitis, Fall, Finger deformity, Folliculitis, Gastrooesophageal reflux disease, Hypoaesthesia, Injury, Mobility decreased, Pain in extremity, Hepatitis, Inflammation, Liver function test increased, Muscular weakness, Neck pain, Pneumonia, Overdose, Intentional product use issue, Off label use, Underdose, Incorrect product administration duration, Abdominal distension, C-reactive protein increased, C-reactive protein abnormal, Confusional state, Contraindicated product administered, Drug hypersensitivity, Drug ineffective, Dyspnoea, Exostosis, Gait disturbance, Hepatic cirrhosis, Ill-defined disorder, Infection, Infusion related reaction, Infusion site reaction, Joint stiffness, Laryngitis, Liver disorder, Lower limb fracture, Lupus-like syndrome, Nausea, Oedema, Onychomadesis, Onychomycosis, Pemphigus, Pericarditis, Product use in unapproved indication, Product use issue, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, hypersomnia type, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Wound, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Coeliac disease, Condition aggravated, Depression, Diarrhoea, Dizziness, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fibromyalgia, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Impaired healing, Inflammation, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal stiffness, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Exposure during pregnancy, Hypersensitivity, Nail disorder, Night sweats, Osteoarthritis, Musculoskeletal pain, Peripheral swelling, Peripheral venous disease, Product label confusion, Psoriatic arthropathy, Stomatitis, Taste disorder, Urticaria, Vomiting, Weight increased, Wheezing, Wound infection, Normal newborn, Obesity, Injection site reaction, Nasopharyngitis, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CANDESARTAN CILEXETIL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LAMOTRIGINE, LAMOTRIGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TETRACYCLINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, NEOMYCIN SULFATE, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, THIAMINE HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXTROMETHORPHAN, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, MAGNESIUM, MEPOLIZUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINERAL OIL AND PETROLATUM, MINERAL OIL AND PETROLATUM, MINERAL OIL AND PETROLATUM, NICOTINAMIDE, HYDROXYCHLOROQUINE SULFATE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CALCIUM CARBONATE, ERGOCALCIFEROL, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 3793 | 25045538 |
AU |
30 | 2 |
Cardiotoxicity, Overdose, Hypoglycaemia, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 3794 | 25045539 |
AU |
64 | 1 |
Cardiotoxicity, Overdose, Hypoglycaemia, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 3795 | 25046670 |
AU |
24 | 2 |
Cardiotoxicity, Overdose, Hypokalaemia, Hypoglycaemia, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 3796 | 25046671 |
AU |
33 | 2 |
Cardiotoxicity, Overdose, Hypokalaemia, Hypoglycaemia, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 3797 | 25046899 |
US |
||
Overdose, |
||||
INCOBOTULINUMTOXINA, |
||||
| 3798 | 25046922 |
US |
2 | |
Overdose, |
||||
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET, FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE, |
||||
| 3799 | 25046924 |
HR |
40 | 1 |
Pallor, Drug abuse, Withdrawal syndrome, Tremor, Incorrect route of product administration, Overdose, Drug interaction, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 3800 | 25046999 |
US |
2 | |
Off label use, Overdose, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30